Це відео не доступне.
Перепрошуємо.
Drug for rare form of ALS benefits some patients
Вставка
- Опубліковано 24 кві 2023
- A new drug has been approved by the Food and Drug Administration (FDA) for a rare, inherited form of amyotrophic lateral sclerosis (ALS) caused by mutations in the gene SOD1. Called tofersen, the drug - developed by Biogen Inc. and based in part on research conducted at Washington University School of Medicine in St. Louis - slowed progression of the fatal, paralyzing disease. Some participants in the phase 3 clinical trial experienced a stabilization of muscle strength and control, encouraging signs for a disease that is normally characterized by continual decline.
For more information: medicine.wustl...
Video by Huy Mach and Tamara Bhandari/Washington University School of Medicine in St. Louis
Thank you! Keep up the great work! 🙏🙏
Iam young girl moon from Quetta Pakistan
What a new treatment please tell me als mnd please tell me
What is new treatment please tell me als mnd
Sir my mother 2 year above suffering to the ALS plz help me sir i am from odisha
Hi sir my name is MOSAROF I'm from Bangladesh 35 year old I'm suffering MND ALS disses one year ago please help me sir
when it connects to ALS TREATMENT AND MS CURE Because I have the Herbs medicine. Visit my page for more information
Hi
Mosarof tomar mobile no daao
Fi amanillah
❤
How can we will get the drag from bd?
Probably not possible
I. Would like to participate 😢please I’m in Usa 🇺🇸
This is for the inherited SQD1 gene carriers
SOD1 gene
What is the drug?
Tofersen
Thank You
Plz help me I am young but Iam Al's mnd.moon from Pakistan😂😂😂